SEC Form 4 insider trading filings tracked in real time from EDGAR

Hansen Gwenn — Chief Scientific Officer

Insider trading activity for Hansen Gwenn sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Scientific Officer
  • Company: Nurix Therapeutics, Inc.
  • Total insider trades: 13
  • Total buy volume: $3K
  • Total sell volume: $235K
  • Last trade: Oct 15, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Oct 15, 2026 Hansen Gwenn NRIX Nurix Therapeutics, Inc. OTHER 1,452 $0
Oct 15, 2026 Hansen Gwenn NRIX Nurix Therapeutics, Inc. SELL 1,452 $36K
Oct 15, 2026 Hansen Gwenn NRIX Nurix Therapeutics, Inc. OTHER 1,452 $3K
Sep 1, 2026 Hansen Gwenn NNRIX NNRIX SELL 1,452 $37K
Sep 1, 2026 Hansen Gwenn NNRIX NNRIX BUY 1,452 $3K
Jun 25, 2026 Hansen Gwenn NRIX Nurix Therapeutics, Inc. SELL 5,394 $108K
Apr 30, 2026 Hansen Gwenn NRIX Nurix Therapeutics, Inc. OTHER 2,858 N/A
Apr 30, 2026 Hansen Gwenn NRIX Nurix Therapeutics, Inc. OTHER 3,750 N/A
Apr 30, 2026 Hansen Gwenn NRIX Nurix Therapeutics, Inc. OTHER 2,000 N/A
Apr 30, 2026 Hansen Gwenn NRIX Nurix Therapeutics, Inc. SELL 3,214 $53K
Apr 30, 2026 Hansen Gwenn NRIX Nurix Therapeutics, Inc. OTHER 2,858 N/A
Apr 30, 2026 Hansen Gwenn NRIX Nurix Therapeutics, Inc. OTHER 3,750 N/A
Apr 30, 2026 Hansen Gwenn NRIX Nurix Therapeutics, Inc. OTHER 2,000 N/A

← All executives · Full trades feed